A popular Asian mushroom has piqued the interest of scientists studying liver fibrosis. A standardized shiitake mycelium extract inhibited this process in mice by simultaneously acting on two different mechanisms. The researchers now want to test its effectiveness in patients with liver fibrosis.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
A popular Asian mushroom has piqued the interest of scientists studying liver fibrosis. A standardized shiitake mycelium extract inhibited this process in mice by simultaneously acting on two different mechanisms. The researchers now want to test its effectiveness in patients with liver fibrosis.